Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Link opens in a new tab
Search content at UTMB Health Research Expert Profiles
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Present and future therapeutic strategies for melioidosis and glanders
D. Mark Estes
, Steven W. Dow
, Herbert P. Schweizer
,
Alfredo G. Torres
Microbiology And Immunology
Research output
:
Contribution to journal
›
Review article
›
peer-review
94
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Present and future therapeutic strategies for melioidosis and glanders'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Antibiotic Discovery
50%
Antibiotic Therapy
50%
B. Pseudomallei
100%
Bioterrorism Agent
50%
Burkholderia Mallei
50%
Burkholderia Pseudomallei
50%
Causative Agents
50%
Destructive Impact
50%
Diabetic
50%
Excess Mortality
50%
Future Therapeutics
100%
Genome Sequence
50%
Glanders
100%
Gram-negative Pathogens
50%
Growing Population
50%
Impact on Public Health
50%
Malicious Use
50%
Malleus
100%
Mandatory Vaccines
50%
Melioidosis
100%
Modern History
50%
New Therapeutics
50%
Novel Therapeutics
50%
Opportunistic Infections
50%
Prophylactic Use
50%
Severe Infection
50%
Target Identification
50%
Therapeutic Applications
50%
Therapeutic Strategies
100%
Medicine and Dentistry
Antibiotic Therapy
25%
Antiinfective Agent
25%
Antimicrobial Agent
25%
Bacterium
25%
Burkholderia mallei
25%
Burkholderia pseudomallei
25%
Diabetes Mellitus
25%
Diseases
50%
Glanders
100%
Infection
25%
Malleus
50%
Melioidosis
100%
Mortality Rate
25%
Opportunistic Infection
25%
Pathogen
100%
Public Health
25%
Target Identification
25%
Therapeutic Use
25%
Pharmacology, Toxicology and Pharmaceutical Science
Antibiotic Therapy
25%
Antiinfective Agent
25%
Antimicrobial Agent
25%
Bacterium
25%
Burkholderia mallei
25%
Burkholderia pseudomallei
25%
Diabetes Mellitus
25%
Diseases
50%
Drug Discovery
25%
Glanders
100%
Infection
25%
Infectious Agent
100%
Melioidosis
100%
Mortality Rate
25%
Opportunistic Infection
25%
Target Identification
25%
Therapeutic Use
25%
Veterinary Science and Veterinary Medicine
Antiinfective Agent
50%
Antimicrobial Agent
100%
Burkholderia mallei
50%
Diseases
100%
Glanders
100%
Infectious Disease
50%
Malleus
100%
Opportunistic Infection
50%
Public Health
50%
Immunology and Microbiology
Antimicrobial Agent
50%
Bacterium
25%
Burkholderia mallei
25%
Burkholderia pseudomallei
25%
Infection
25%
Infectious Agent
100%
Infectious Disease
25%
Mortality Rate
25%
Opportunistic Infection
25%